GP
KITE

GLG Partners’s Kite Pharma, Inc. KITE Stock Holding History

GLG Partners’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-72,618
Closed -$13.1M – 558
2017
Q3 		$13.1M Buy
+72,618
New +$10.1M 0.69% 35

GLG Partners's KITE Position: Q4 2017 in Review

GLG Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 72,618 shares — an estimated $13.1M sold.

GLG Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $13.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • GLG Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • GLG Partners sold 72,618 Kite Pharma, Inc. shares in Q4 2017, an estimated $13.1M.
  • GLG Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • GLG Partners's Kite Pharma, Inc. position peaked at $13.1M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.